Augmented autologous stem cell transplant (ASCT-aug) clinical trials

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

This study looks at new ways to treat multiple myeloma that has come back after initial treatment. It compares standard stem cell transplants with a boosted stem cell transplant, and then explores whether ongoing treatment helps keep the cancer away for longer.